Abstract
The association between current beta-1-selective beta-blocker use and cognitive function was evaluated in 722 patients with coronary artery disease without dementia. Beta-1-selective beta-blocker use was associated with worse incidental learning independently of sociodemographic characteristics, clinical coronary artery disease severity, and depression/anxiety.
Cite
CITATION STYLE
Burkauskas, J., Noreikaite, A., Bunevicius, A., Brozaitiene, J., Neverauskas, J., Mickuviene, N., & Bunevicius, R. (2016). Beta-1-selective beta-blockers and cognitive functions in patients with coronary artery disease: A cross-sectional study. Journal of Neuropsychiatry and Clinical Neurosciences, 28(2), 143–146. https://doi.org/10.1176/appi.neuropsych.15040088
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
